Adcendo raised $135M in a Series B funding round led by TCGX to advance its ADC pipeline for treating cancers.
Amount Raised
$135 Million
Round Type
Series B
FrederiksbergBiotechnologyHealth CareInvestors
Description
Adcendo, a Copenhagen-based biotech company, closed $135M in Series B financing to enhance the development of its ADC programs. The funding round witnessed participation from several new and existing investors aimed at addressing high unmet medical needs in cancer treatment.
Quick answer
Adcendo raised $135 Million in a Series B round, dated November 25, 2024. Investors: Pontifax Venture Capital, RA Capital Management, Logos Capital, Gilde Healthcare, Dawn Biopharma, Ysios Capital, Venrock Healthcare Capital Partners and Surveyor Capital. Adcendo is based in Frederiksberg, Capital Region of Denmark, Denmark.
- How much did Adcendo raise?
- Adcendo raised $135 Million in a Series B round on November 25, 2024.
- Who invested in Adcendo?
- Pontifax Venture Capital, RA Capital Management, Logos Capital, Gilde Healthcare, Dawn Biopharma, Ysios Capital, Venrock Healthcare Capital Partners and Surveyor Capital are named as investors in this round.
- What does Adcendo do?
- Adcendo is a Danish clinical-stage biotech company headquartered in Copenhagen, dedicated to the development of highly differentiated First-In-Class Antibody-drug conjugates (ADCs) for treatment of solid tumors.
- Where is Adcendo based and how big is it?
- Adcendo is based in Frederiksberg, Capital Region of Denmark, Denmark.
- Who are the decision-makers at Adcendo?
- Fundz holds 1 contact at Adcendo. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Adcendo that raised within 45 days of this round, from Fundz verified event records.
- Verdiva Bio raised $411M (Series A) on January 9, 2025.
- Oxford Cancer Analytics raised $11M (Series A) on January 9, 2025.
- RyboDyn raised $4M (Pre-Seed) on January 9, 2025.
- Aspect Biosystems raised $115M (Series B) on January 8, 2025.
- Geneoscopy raised $105M (Series C) on January 8, 2025.
- Tenvie Therapeutics raised $200M (Funding Round) on January 8, 2025.
Who to call at Adcendo, and when
A new round usually means Adcendo is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adcendo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adcendo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adcendo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adcendo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAdcendo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.